Cohance Lifesciences MD sells shares to meet financial obligations

Dr. V Prasada Raju, managing director of Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited), sold 600,000 company shares on August 26, 2025. This transaction was valued at Rs. 52.82 crores. Following the sale, Dr. Raju's shareholding in Cohance Lifesciences decreased from 0.19% to 0.03%.

The sale was primarily undertaken to repay a loan availed for exercising stock options under the ESOP scheme, cover associated tax obligations, and discharge other personal liabilities. Dr. Raju affirmed his continued dedication to the company's strategic vision.

This disclosure was made under the SEBI (Prohibition of Insider Trading) Regulations, 2015, to ensure transparency with stock exchanges and all stakeholders. The company, through its company secretary and compliance officer, Kundan Kumar Jha, submitted the necessary filings to both BSE and NSE.